0001179110-15-006161.txt : 20150409
0001179110-15-006161.hdr.sgml : 20150409
20150409075714
ACCESSION NUMBER: 0001179110-15-006161
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150409
FILED AS OF DATE: 20150409
DATE AS OF CHANGE: 20150409
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001360886
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 710881115
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
BUSINESS PHONE: 443-545-1819
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danilkovitch Alla
CENTRAL INDEX KEY: 0001636236
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32966
FILM NUMBER: 15760359
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
STREET 2: OSIRIS THERAPEUTICS, INC.
CITY: COLUMBIA
STATE: MD
ZIP: 21046
3
1
edgar.xml
FORM 3 -
X0206
3
2015-04-09
0
0001360886
OSIRIS THERAPEUTICS, INC.
OSIR
0001636236
Danilkovitch Alla
C/O OSIRIS THERAPEUTICS, INC.
7015 ALBERT EINSTEIN DRIVE
COLUMBIA
MD
21046-1707
0
1
0
0
Chief Scientific Officer
Common Stock
5375
D
Non-Qualified Stock Option (right to buy)
0.40
2006-12-01
2015-12-01
Common Stock
5000
D
Incentive Stock Option (right to buy)
12.50
2008-07-26
2017-07-26
Common Stock
3000
D
Incentive Stock Option (right to buy)
17.10
2009-10-02
2018-10-02
Common Stock
3000
D
Incentive Stock Option
7.74
2011-03-12
2020-03-12
Common Stock
8000
D
Incentive Stock Option (right to buy)
6.46
2011-05-27
2020-05-27
Common Stock
5000
D
Incentive Stock Option (right to buy)
7.13
2012-02-14
2021-02-14
Common Stock
9000
D
Incentive Stock Option (right to buy)
5.08
2013-03-23
2022-03-23
Common Stock
10000
D
Incentive Stock Option (right to buy)
7.73
2013-02-12
2023-02-12
Common Stock
10000
D
Non-Qualified Stock Option (right to buy)
14
2015-05-06
2024-05-06
Common Stock
1436
D
Incentive Stock Option (right to buy)
14
2015-05-06
2024-05-06
Common Stock
18564
D
Non-Qualified Stock Option (right to buy)
18.40
2016-03-06
2025-03-06
Common Stock
17356
D
Incentive Stock Option (right to buy)
18.4
2016-03-06
2025-03-06
Common Stock
7644
D
The option to purchase shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to the underlying shares as of the date of this Form 3.
The option to purchase 10,000 shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to 7,500 of the underlying shares and the remaining 2,500 options shall become exercisable on March 23, 2016, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
The option to purchase 10,000 shares of Osiris Therapeutics, Inc. common stock is immediately exercisable with respect to 5,000 of the underlying shares and the remaining 5,000 options shall become vested, 2,500 on February 12, 2016 and 2,500 on February 12, 2017, assuming the Reporting Person continues to be employed by the Registrant on the vesting dates.
The option to purchase 20,000 shares of Osiris Therapeutics, Inc. common stock shall become exercisable with respect to the underlying shares as to 25% on each May 6, 2015, 2016, 2017 and 2018, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
The option to purchase 25,000 shares of Osiris Therapeutics, Inc. common stock shall become exercisable with respect to the underlying shares as to 25% on each March 6, 2016, 2017, 2018 and 2019, assuming the Reporting Perosn continues to be employed by the Registrant on the vesting date
Alla Danilkovitch
2015-04-09